Peter DeYoung

Peter DeYoung

Chief Executive Officer at PIRAMAL PHARMA LIMITED

Net worth: 3 M $ as of 2026-06-29

48 year
Health Technology
Commercial Services
Consumer Services

Profile

Peter D. DeYoung is Chief Executive Officer of Piramal Critical Care, Inc., Chief Executive Officer of Piramal Pharma Solutions, Inc., Chief Executive Officer for Piramal Enterprises Ltd. and Director at Montane Ventures Pvt Ltd. Mr. DeYoung is also on the board of Piramal Imaging SA and Piramal Pharma Ltd. Mr. DeYoung previously was President of Piramal Phytocare Ltd. Peter D. DeYoung received an undergraduate degree from Princeton University and an MBA from Stanford University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.05%
2025-12-30 108,000 ( 0.05% ) 2 M $ 2026-06-29
2025-12-30 432,000 ( 0.03% ) 767 625 $ 2026-06-29

Peter DeYoung active positions

CompaniesPositionStart
PIRAMAL PHARMA LIMITED Chief Executive Officer 2020-03-03
Chief Executive Officer -
Corporate Officer/Principal -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Piramal Critical Care Italia SpA
Director/Board Member -
Director/Board Member -
PEL Pharma, Inc.
Director/Board Member -
░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
░░░░░░░ ░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -

Former positions of Peter DeYoung

CompaniesPositionEnd
░░░░░ ░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░ ░░░░░░░░ ░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ -
░░░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░ -
░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of Peter DeYoung's experience

Training of Peter DeYoung

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

37

1st degree connections

21

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies21

Consumer Services

Finance

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Health Technology

Finance

Health Technology

Commercial Services

Health Technology

Piramal Global Pharma

Health Technology

Piramal Critical Care Italia SpA

PEL Pharma, Inc.